Doggydogworld
Active Member
Why the heck does he call it a rebound instead of a relapse? Anyway, the 1-2% found in the clinical trial was only those who tested negative then positive, or who showed a period of increasing viral load after end of the treatment. It happened in both the placebo and Paxlovid groups. And most of those people did not have a recurrence of symptoms. The opinion piece says the percentage who have symptom relapse is probably much higher, and I agree. In general Covid seems to be pretty hard to shake.Opinion: Rebound after taking Paxlovid is the latest twist in the Covid-19 puzzle
A mostly opinion-piece with few hard numbers, but was still interesting to read (for me).
Also the linked FDA-update:
FDA Updates on Paxlovid for Health Care Providers